Plaintiffs and the company vowed to renegotiate but the talks will be challenging after the court struck down a provision the Sacklers had insisted on in exchange for $6 billion. Plaintiffs and the company vowed to renegotiate but the talks will be challenging after the court struck down a provision the Sacklers had insisted on in exchange for $6 billion. Purdue Pharma, Sackler Family, Opioids and Opiates, OxyContin (Drug), Drug Abuse and Traffic, Bankruptcies, Suits and Litigation (Civil), Deaths (Fatalities), Justice Department, Office of the United States Trustee, Decisions and Verdicts, Supreme Court (US), your-feed-healthcare NYT > Science